The role of factors involved in proliferation processes in the pathogenesis of adenomyosis
https://doi.org/10.18699/SSMJ20260208
Abstract
The study of the expression of proliferation factors by immunohistochemistry is necessary to determine their role in the pathogenesis of the disease and to develop new diagnostic methods and pathogenetically based therapy. Aim of the study was to evaluate the expression of factors involved in proliferation processes (stress-induced phosphoprotein 1 (STIP1), phosphatase and tensin homologue (PTEN)) in the endometrium of reproductive-age patients with adenomyosis. Material and methods. 45 women aged 18 to 35 years were examined. The main group consisted of 34 patients with adenomyosis, the control group included 11 healthy women. Endometrial sampling was performed during hysteroscopy or by aspiration biopsy in the proliferative and secretory phases of the menstrual cycle. Histological and immunohistochemical studies of the endometrium were performed to assess the expression of STIP1 and PTEN. Results. The expression of STIP1 is statistically significantly higher in the glandular component of the endometrium of patients with adenomyosis compared with the control group in the secretory phase of the menstrual cycle (p < 0.05). There were no significant differences in PTEN expression in the endometrium between the groups, regardless of the phase of the menstrual cycle. Conclusions. Increased expression of STIP1 in the glandular component of the endometrium of patients with adenomyosis in the secretory phase of the menstrual cycle may be one of the reasons for the imbalance of proliferation and apoptosis in adenomyosis. In order to determine the role of PTEN in the pathogenesis of adenomyosis, it may be necessary to determine its phosphorylated form, as well as use other research methods
About the Authors
A. K. Beganova
The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott
Russian Federation
Russian Federation
Aleksandra K. Beganova
199034, Saint-Petersburg, Mendeleevskaya ln., 3
M. I. Yarmolinskaya
The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott
Russian Federation
Russian Federation
Maria I. Yarmolinskaya, doctor of medical sciences, professor of RAS, professor
199034, Saint-Petersburg, Mendeleevskaya ln., 3
M. A. Shalina
The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott
Russian Federation
Russian Federation
Maria A. Shalina, candidate of medical sciences
199034, Saint-Petersburg, Mendeleevskaya ln., 3
T. G. Tral
The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott
Russian Federation
Russian Federation
Tatyana G. Tral, doctor of medical sciences
199034, Saint-Petersburg, Mendeleevskaya ln., 3
G. Kh. Tolibova
The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott
Russian Federation
Russian Federation
Gulrukhsor Kh. Tolibova, doctor of medical sciences
199034, Saint-Petersburg, Mendeleevskaya ln., 3
References
1. Abbott J.A. Adenomyosis and abnormal uterine bleeding (AUB-A) – Pathogenesis, diagnosis, and management. Best Pract. Res. Clin. Obstet. Gynaecol. 2017;40:68–81. doi: 10.1016/j.bpobgyn.2016.09.006
2. Loring M., Chen T.Y., Isaacson K.B. A systematic review of adenomyosis: It is time to reassess what we thought we knew about the disease. J. Minim. Invasive Gynecol. 2021;28(3):644–655. doi: 10.1016/j.jmig.2020.10.012
3. Upson K., Missmer S.A. Epidemiology of adenomyosis. Semin. Reprod. Med. 2020;38(2-03):89–107. doi: 10.1055/s-0040-1718920
4. Puente J.M., Fabris A., Patel J., Patel A., Cerrillo M., Requena A., Garcia-Velasco J.A. Adenomyosis in infertile women: prevalence and the role of 3D ultrasound as a marker of severity of the disease. Reprod. Biol. Endocrinol. 2016;14(1):60. doi: 10.1186/s12958-016-0185-6
5. Mishra I., Melo P., Easter C., Sephton V., Dhillon-Smith R., Coomarasamy A. Prevalence of adenomyosis in women with subfertility: systematic review and meta-analysis. Ultrasound Obstet. Gynecol. 2023;62(1):23–41. doi: 10.1002/uog.26159
6. Endometriosis. Clinical recommendations. Moscow: Ministry of Health of the Russian Federation. ROAG; 2020:60. [In Russian]. Available at: https://yadi.sk/i/yYPwxWe4uTZcWg
7. Shalina M.A., Yarmolinskaya M.I., Netreba E.A., Beganova A.K. Role of molecular signaling pathways in the pathogenesis of adenomyosis. Zhurnal akusherstva i zhenskikh bolezney = Journal of Obstetrics and Women’s Diseases. 2021;70(3):121–134. [In Russian]. doi: 10.17816/JOWD57192
8. Glaviano A., Foo A.S.C., Lam H.Y., Yap K.C.H., Jacot W., Jones R.H., Eng H., Nair M.G., Makvandi P., Geoerger B., Kulke M.H., Baird R.D., Prabhu J.S., Carbone D., Pecoraro C., Teh D.B.L., Sethi G., Cavalieri V., Lin K.H., Javidi-Sharifi N.R., Toska E., Davids M.S., Brown J.R., Diana P., Stebbing J., Fruman D.A., Kumar A.P. PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer. Mol. Cancer. 2023;22(1):138. doi: 10.1186/s12943-023-01827-6
9. Cho H., Kim S., Shin H.Y., Chung E.J., Kitano H., Hyon Park J., Park L., Chung J.Y., Hewitt S.M., Kim J.H. Expression of stress-induced phosphoprotein1 (STIP1) is associated with tumor progression and poor prognosis in epithelial ovarian cancer. Genes Chromosomes Cancer. 2014;53(4):277–288. doi: 10.1002/gcc.22136
10. Tsai C.L., Chao A., Jung S.M., Tsai C.N., Lin C.Y., Chen S.H., Sue S.C., Wang T.H., Wang H.S., Lai C.H. Stress-induced phosphoprotein-1 maintains the stability of JAK2 in cancer cells. Oncotarget. 2016;7(31):50548–50563. doi: 10.18632/oncotarget.10500
11. Tang Y., Yan G., Song X., Wu K., Li Z., Yang C., Deng T., Sun Y., Hu X., Yang C., Bai H., Li H., Tan W., Ye M., Liu J. STIP overexpression confers oncogenic potential to human non-small cell lung cancer cells by regulating cell cycle and apoptosis. J. Cell Mol. Med. 2015;19(12):2806–2817. doi: 10.1111/jcmm.12670
12. Zhai J., Vannuccini S., Petraglia F., Giudice L.C. Adenomyosis: Mechanisms and pathogenesis. Semin. Reprod. Med. 2020;38(2-03):129–143. doi: 10.1055/s0040-1716687
13. Xu X.Y., Zhang J., Qi Y.H. Kong M., Liu S.A., Hu J.J. Linc-ROR promotes endometrial cell proliferation by activating the PI3K-Akt pathway. Eur. Rev. Med. Pharmacol. Sci. 2018;22(8):2218–2225. doi: 10.26355/eurrev_201804_14807
14. Zheng D., Duan H., Wang S., Xu Q., Gan L., Li J., Dong Q. FAK regulates epithelial-mesenchymal transition in adenomyosis. Mol. Med. Rep. 2018;18(6):5461–5472. doi: 10.3892/mmr.2018.9600
15. Hu H., Li H., He Y. MicroRNA-17 downregulates expression of the PTEN gene to promote the occurrence and development of adenomyosis. Exp. Ther. Med. 2017;14(4):3805–3811. doi: 10.3892/etm.2017.5013
16. Hale G.E., Zhao X., Hughes C.L., Burger H.G., Robertson D.M., Fraser I.S. Endocrine features of menstrual cycles in middle and late reproductive age and the menopausal transition classified according to the Staging of Reproductive Aging Workshop (STRAW) staging system. J. Clin. Endocrinol. Metab. 2007;92(8):30603067. doi: 10.1210/jc.2007-0066
17. Perevalova A.M., Kobelev V.S., Sisakyan V.N., Gulyaeva L.F., Pustyl’nyak V.O. Role of tumor suppressor PTEN and its regulation in malignant transformation of endometrium. Biochemistry (Mosc.). 2022;87(11):1310–1326. doi: 10.31857/S0320972522110057
18. Wang H.S., Tsai C.L., Chang P.Y., Chao А., Wu R.C., Chen S.H., Wang С.J., Yen C.F., Lee Y.S., Wang T.H. Positive associations between upregulated levels of stress-induced phosphoprotein 1 and matrix metalloproteinase-9 in endometriosis/adenomyosis.PLoS. ONE. 2018;13(1):e0190573. doi: 10.1371/journal.pone.0190573
19. Chen D., Zhou L., Qiao H., Wang Y., Xiao Y., Fang L., Yang B., Wang Z. Comparative proteomics identify HSP90A, STIP1 and TAGLN-2 in serum extracellular vesicles as potential circulating biomarkers for human adenomyosis. Exp. Ther. Med. 2022;23(6):374. doi: 10.3892/etm.2022.11301
20. Yarmolinskaya M.I., Ailamazyan E.K. Genital en dometriosis. Different facets of the problem. Saint-Petersburg: Eko-Vektor, 2017. 615 p. [in Russian]
21. Khan K.N., Kitajima M., Imamura T., Hiraki K., Fujishita A., Sekine I., Ishimaru T., Masuzaki H. Toll-like receptor 4-mediated growth of endometriosis by human heat-shock protein 70. Hum. Reprod. 2008;23(10):2210–2219. doi: 10.1093/humrep/den195
Review
Views:
372
JATS XML
Email this article 